The Agatston score is a predictor of contrast-induced nephropathy in patients with stable coronary artery disease after percutaneous coronary intervention

The Agatston score is a predictor of contrast-induced nephropathy in patients with stable coronary artery disease after percutaneous coronary intervention

Saved in:

Bibliographic Details
Main Authors:	Fatih Sivri, Yahya K. Içen, Fatih Aksoy, Hasan Koca, Mevlüt Koç
Format:	Article
Language:	English
Published:	Termedia Publishing House 2024-11-01
Series:	Advances in Interventional Cardiology
Subjects:	percutaneous coronary intervention stable coronary artery disease agatston score contrast-induced nephropathy
Online Access:	https://www.termedia.pl/The-Agatston-score-is-a-predictor-of-contrast-induced-nephropathy-in-patients-with-stable-coronary-artery-disease-after-percutaneous-coronary-intervention,35,55094,1,1.html
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Contrast-induced Nephropathy: Incidence and Reversibility in Patients Undergoing High-risk Percutaneous Coronary Intervention
by: Bharat Singh Sambyal, et al.
Published: (2025-01-01)

Stabilizing Stable Coronary Artery Disease
by: Kuan-Yu Chi, MD, et al.
Published: (2025-02-01)

CONTRAST-INDUCED ACUTE KIDNEY INJURY AFTER PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE
by: O. Iu. Mironova, et al.
Published: (2020-12-01)

Preoperative hemoglobin predicts clinical outcomes after percutaneous coronary intervention
by: Hailang Liu, et al.
Published: (2025-04-01)

Prognostic Value of Cardiac Troponin T and Sex in Patients Undergoing Elective Percutaneous Coronary Intervention
by: Yukinori Harada, et al.
Published: (2016-12-01)

CONTRAST-INDUCED NEPHROPATHY IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE AND 1-YEAR PROGNOSIS
by: O. Iu. Mironov, et al.
Published: (2020-09-01)

Predictive Significance of the Monocyte-to-High-Density Lipoprotein Cholesterol Ratio in Post-Percutaneous Coronary Intervention Contrast-Induced Nephropathy Among Patients with Coronary Artery Disease
by: Lin A, et al.
Published: (2025-07-01)

Diagnostic Potential of CTRP5 and Chemerin for Coronary Artery Disease: A Study by Coronary Computed Tomography Angiography
by: Taha Okan, et al.
Published: (2025-01-01)

Predictive value of urinary triggering receptors expressed on myeloid cells-1 on contrast-induced nephropathy after percutaneous coronary intervention
by: Lai Dong-yan, et al.
Published: (2022-04-01)

Comparability of cardiovascular risk assessment according to the SCORE and the coronary artery calcium score (Agatston score)
by: A. S. Safaryan, et al.
Published: (2023-11-01)

HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE?
by: I. S. Yavelov, et al.
Published: (2017-09-01)

The prognostic association of triglyceride-glucose index and its derived indicators with stable coronary artery disease patients undergoing percutaneous coronary intervention
by: Yu Shan, et al.
Published: (2025-01-01)

IMMEDIATE RESULTS OF DELAYED PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: S. D. Chevgun, et al.
Published: (2017-12-01)

Immediate and short-term outcomes of percutaneous coronary intervention in patients with stable and multivessel coronary artery disease, intolerant to coronary artery bypass grafting
by: Sh. Sh. Zaynobidinov, et al.
Published: (2025-05-01)

PERCUTANEOUS INTERVENTION IN STABLE ANGINA: WHAT ISSUES DO WE SOLVE?
by: Yu. A. Karpov, et al.
Published: (2018-04-01)

Management of Coronary Vulnerable Plaques: A Focus on Preventive Percutaneous Coronary Intervention
by: Stefano Rigattieri, et al.
Published: (2025-04-01)

Risk factors of contrast-induced nephropathy after coronary angiography and the countermeasures
by: YANG Shu-mei, et al.
Published: (2016-01-01)

Research progress on coronary slow flow or no-reflow of coronary heart disease undergoing percutaneous coronary intervention surgery
by: Mengdi Wang, et al.
Published: (2025-01-01)

Percutaneous Coronary Interventions: what the general practitioner should know
by: J.M. Bennett
Published: (2005-02-01)

When Prevention is Truly Better than Cure: Contrast-Associated Acute Kidney Injury in Percutaneous Coronary Intervention
by: Isaac Tea, et al.
Published: (2022-09-01)

The Role of Hydration and N-Acetyl Cysteine Combination in 48 Hours Contrast-Induced Nephropaty after Percutaneous Coronary Intervention in Stage Three Chronic Kidney Disease Patients
by: Lydia D Simatupang, et al.
Published: (2016-09-01)

BIVALIRUDIN AND PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME: THEORY AND PRACTICE
by: O. V. Averkov
Published: (2012-06-01)

The Effect of Intravascular Imaging-Guided Percutaneous Coronary Intervention on Coronary Artery Perforation
by: Yuichi Sawayama, MD, et al.
Published: (2025-01-01)

Epidemiological Profile of Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome in a Single Tertiary Center in Basrah, Iraq
by: Ola Murtadaa Albattat, et al.
Published: (2025-06-01)

The role of coronary artery calcium scoring in the prediction of coronary artery disease based on non-contrast non-cardiac chest CT scans in airline pilots
by: Lin Zhang, et al.
Published: (2025-04-01)

Critical endpoints in dynamic follow-up of anemia patients with percutaneous coronary intervention for acute coronary syndrome
by: Margarita A. Simonyan, et al.
Published: (2023-12-01)

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With 3‐Vessel Coronary Artery Disease and Diabetes
by: Ryaan EL‐Andari, et al.
Published: (2025-06-01)

ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS
by: V. A. Sulimov
Published: (2016-01-01)

Contrast-induced nephropathy in patients with acute coronary syndrome with ST-segment elevation: risk factors and prognosis
by: O. V. Arsenicheva, et al.
Published: (2020-01-01)

Correlation Between Lipoprotein(a) and Prognosis for Coronary Artery Disease in Patients Undergoing Percutaneous Coronary Intervention
by: Azhi ShaMa, MM, et al.
Published: (2024-12-01)

Effect of Percutaneous Coronary Intervention on Quality of Life among Coronary Artery Disease Patients in Erbil City
by: Chnarb Salahaddin Qadir, et al.
Published: (2025-05-01)

THE ROLE OF PULSE REDUCTION THERAPY IN ADDITIONAL IMPROVEMENT OF CLINICAL EFFECTS OF MYOCARDIAL REVASCULARIZATION IN CORONARY HEART DISEASE STABLE ANGINA PATIENTS
by: D. M. Aronov, et al.
Published: (2018-06-01)

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2019-05-01)

Comorbidities and Percutaneous Coronary Intervention in Elderly Patients with Acute Coronary Syndrome
by: M. Yu. Gilyarov, et al.
Published: (2021-05-01)

Effect of rosuvastatin 20 mg pretreatment before percutaneous coronary intervention in patients with acute coronary syndrome
by: Sungho Jo, et al.
Published: (2025-05-01)

Contrast-induced nephropathy after recanalization chronic coronary occlusion in patients with renal artery stenosis and normal creatinine levels
by: N. A. Yaitskiy, et al.
Published: (2023-10-01)

Prognostic value of global coronary flow reserve before and after elective percutaneous coronary intervention in patients with chronic coronary syndrome
by: Kai Nogami, et al.
Published: (2024-01-01)

Characteristics of patients with coronary artery disease and type 2 diabetes mellitus undergoing elective percutaneous coronary intervention
by: Anastasiya G. Neeshpapa, et al.
Published: (2025-01-01)

Indobufen versus aspirin after percutaneous coronary intervention in elderly patients with acute coronary syndrome
by: Wenbo Dai, et al.
Published: (2025-07-01)

Acute Coronary Syndrome after Percutaneous Coronary Intervention: State of the Problem and Clinical Practice Data
by: I. S. Egorova, et al.
Published: (2023-01-01)